TNF-α is produced in high concentrations in chronic inflammatory disease, resulting in excessive inflammation which eventually leads to organ damage. The advent of anti-TNF therapy in clinical practice 20 years ago represented a significant change in the management of immune-mediated inflammatory diseases (IMIDs), including rheumatoid arthritis (RA), axial spondylarthritis (SpA), psoriasis, and inflammatory bowel disease (IBD).

Discover Professor Antoni Bayés-Genís’ view on the evolution of left ventricular assist devices and his comments related to the AHA/ACC/HFSA guidelines in comparison to the 2021 ESC heart failure guidelines.

CoMiSSTM is a clinical tool developed to increase awareness among healthcare professionals (HCP) of possible symptoms of cow’s milk allergy (CMA) in infants. During this symposium, leading experts in the field of paediatric gastroenterology, allergy, and nutrition highlighted how CoMiSS can facilitate awareness of CMA and support HCPs in improving the patient journey from symptom presentation to diagnosis.

This Bayer-sponsored symposium titled ‘Advancing patient care in the evolving prostate cancer treatment landscape (HYBRID)’ took place…

A multidisciplinary team (MDT) approach is considered the gold standard for the diagnosis and treatment of cancer.